Private limited company · founded 2016 · active for 10 yearsSint - Jansdreef 18, 9900 Eeklo, BelgiumKBO/BCE: BE 0658.939.608
Summary
PHARMA4L is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.4m and a net result of €242,951. Equity is growing by about 31% per year across the filed financial years. Its solvency ranks better than 62% of 6,640 sector peers (NACE 64, financial year 2025). The company has been active since 2016 and the Belgian Official Gazette contains no insolvency or warning signals.
The company's story in a few sentences, from the company register, the Belgian Official Gazette and the filed annual accounts. Each number opens the document the sentence rests on.
On 12 July 2016, PHARMA4L was incorporated.1Total assets went from €1.8m in 2018 to €2.1m in 2025.2
A profit in every financial year since 2018 builds equity to €614,185.
31-08
NBB filingAnnual accounts filed
financial year 2020 · abbreviated format · 31 days late
2020
20-10
NBB filingAnnual accounts filed
financial year 2019 · abbreviated format · 81 days late
2019
30-08
NBB filingAnnual accounts filed
financial year 2018 · micro format · 30 days late
2018
31-08
NBB filingAnnual accounts filed
financial year 2017 · micro format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.